- Home
- ยป
- Our Products
- »
- Antibiotic Medicines
Antibiotic Medicines
Erythromycin Stearate Tablets BP (ERYSTY)
| Packaging Type | Blister |
| Also gives | Third Party Manufacturing |
| Country of Origin | Made in India |
| Strength | 250 mg |
| BRAND NAME | ERYSTY |
| Shelf | 36 months |
INDICATION:Infections due to susceptible micro-organisms such as gram positive cocci and bacilli. Erythromycin stearate has been found to be effective in vitro against Gram-positive organisms such as Staphylococcus aureus, Streptococcus pyogenes and Streptococcus viridans , enterococci and pneumococci. It also inhibits some strains of Neisseriae, Haemophilus influenzae, Corynebacterium diphtheriae, Listeria, Pasteurella and Treponema. Upper and lower respiratory tract infections due to Streptococcus pyogenes, Haemophilus influenzae and Mycoplasma pneumoniae. Erythromycin stearate is an alternate treatment for Neisseria gonorrhoea and primary syphilis in patients allergic to the penicillins. Before treatment of gonorrhoea patients who are suspected of also having syphilis should have a microscopic examination for T. pallidum.Erythromycin is successful as adjunctive therapy to the antitoxin in the treatment of tetanus. The drug has also proved to be successful in the treatment of infections due to Bordetella pertussis and Listeria monocytogenes.
DOSAGE AND ADMINISTRATION:In order to obtain optimal blood levels, Erysty should be given on an empty stomach. For adults: 200 mg for 6 hours & 500 mg for every 12 hours.For children: The basic recommendation ranges from 30 to 50 mg/kg/day or more, depending on the severity of the infections: these amounts are administered in four divided doses.Dosage schedule for specific indications: In streptococcal infections, erythromycin stearate should be administered at therapeutic dosage for at least 10 days. For continuous prophylaxis of streptococcal infections or rheumatic fever recurrences in persons with a history of rheumatic heart disease, the dose is 250 mg twice a day. When used prior to surgery to prevent endocarditis a recommended schedule for adults is 1 g before the procedure and 500 mg every 6 hours for 8 doses after the procedure.Treatment of primary syphilis: 30 - 40 grams per day given in divided doses over a period of 10 to 15 days.Treatment of N.gonorrhoea: 500 mg every 6 hours for 3 days.
Additional Information:
- Packaging Details: 10x10 Tablets in printed carton with pack insert.
Metrodev (Metronidazole Oral Suspension BP)
Product Brochure
| Strength | 200mg/5ml |
| Pack Size | 60 ml |
| Pack Type | Bottle |
| Brand Name | Metrodev |
| Manufacturer Name | Devlife Corporation pvt ltd. |
INDICATION:Metronidazole Oral Suspension is indicated in the prophylaxis and treatment of infections in which anaerobic bacteria have been identified or are suspected as the pathogen.Adults, Children and Newborns with a gestation age of over 40 weeks for: treatment of septicaemia, bacteraemia, brain abscess, necrotising pneumonia, osteomyelitis, puerperal sepsis, pelvic abscess, pelvic cellulitis, peritonitis and post-operative wound infections from which one or more pathogenic anaerobes have been isolated.Adults and Children over 10 years only for: Bacterial vaginosis, Acute dental infections, Anaerobically infected leg ulcers and pressure sores.Adults and Children for: treatment of urogenital trichomoniasis in the female (trichomonal vaginitis) and in the male. Amoebiasis, Giardiasis, Acute ulcerative gingivitis.Children for: Eradication of Helicobacter pyloriConsideration should be given to official guidance on the appropriate use of antibacterial agents.
Ceftriaxone 1g Injection USP
| Brand Name | DEVCEF 1000 |
| Strength | 1 gm |
| Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
| Injection Site | IV & IM |
| Form | Injection |
| Dosage | As directed by the physician. |
| Composition | Each vial contains: |
| Also gives | Third Party Manufacturing |
| Packaging Type | Glass Ampoules |
| Treatment | Antibiotics |
| Shelf life | 2 Years |
| Country of Origin | Made in India |
DEVCEF 1000
COMPOSITION:
Each vial contains:
Ceftriaxone Sodium USP
Eq. to Ceftriaxone .. 1g
Pharmacotherapeutic group
J01DA13 - Cephalosporins and related substances.
Pharmacodynamic effects : Ceftriaxone exerts in vitro activity against a wide range of Gram-negative and Gram-positive microorganisms. Ceftriaxone is highly stable to most beta-lactamases, both the penicillinases and cephalosporinases, of Gram-positive and Gram-negative bacteria.
Antibiotic class : Long acting, broad spectrum semi-synthetic cephalosporin for intramuscular or intravenous administration.
Antibiotic nature and mode of action : The bactericidal activity of ceftriaxone results from inhibition of bacterial cell wall synthesis.
Indications: Infections caused by pathogens sensitive to Ceftriaxone Injection, e.g.: sepsis; meningitis; abdominal infections (peritonitis, infections of the biliary and gastrointestinal tracts); infections of the bones, joints, soft tissue, skin and of wounds; infections in patients with impaired defence mechanisms; renal and urinary tract infections; respiratory tract infections, particularly pneumonia, and ear, nose and throat infections; genital infections, including gonorrhoea. Perioperative prophylaxis of infections.
Specification :
- Infections caused by pathogens sensitive to Ceftriaxone Injection (sepsis, meningitis)
-abdominal infections
-infections of the bones, joints, soft tissue, skin and of wounds
-renal and urinary tract infections
-respiratory tract infections
-pneumonia, and ear, nose and throat infections
-genital infections
Additional Information:
- Packaging Details: Single Vial with 10ml WFI in tray with printed carton with pack insert.